DRMAW β€” DERMATA THERAPEUTICS INC

Ownership history in UBS Group AG  Β·  15 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in DERMATA THERAPEUTICS INC (DRMAW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)    DRMAW price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 1,279 -601 -32.0% 0.00% $22 β€”
2025 Q2 REDUCED 1,880 -737 -28.2% 0.00% $34 β€”
2025 Q1 REDUCED 2,617 -1,525 -36.8% 0.00% $44 β€”
2024 Q4 REDUCED 4,142 -100 -2.4% 0.00% $46 β€”
2024 Q3 REDUCED 4,242 -800 -15.9% 0.00% $42 β€”
2024 Q2 ADDED 5,042 +3,557 +239.5% 0.00% $71 β€”
2024 Q1 REDUCED 1,485 -1,868 -55.7% 0.00% $15 β€”
2023 Q4 REDUCED 3,353 -2,257 -40.2% 0.00% $23 β€”
2023 Q3 ADDED 5,610 +3,810 +211.7% 0.00% $101 β€”
2023 Q1 REDUCED 1,800 -5,105 -73.9% 0.00% $36 β€”
5 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding DRMAW

As of 2025 Q4 β€” sorted by position size

BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.0% SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0%
← Back to UBS Group AG Holdings